microbiology, Vol 141, 1829-1837, Copyright © 1995 by Society for General Microbiology

ARTICLES

Unusual effect of myo-inositol on phospholipid biosynthesis in Cryptococcus neoformans

VL Vincent and LS Klig
Department of Biological Sciences, California State University Long Beach 90840, USA.

Cryptococcus neoformans is an opportunistic fungal pathogen which preferentially localizes to the inositol-rich environment of the central nervous system. One of its distinguishing traits is its capacity to catabolize inositol. Inositol is a precursor for the synthesis of phosphatidylinositol (PI). This study demonstrated that C. neoformans synthesizes inositol. Three inositol-containing sphingolipids were identified in C. neoformans: ceramide-(P- inositol)2mannose, mannose, ceramide-P-inositol-mannose, and ceramide-P- inositol. These inositol-containing sphingolipids are typical of fungi but not higher eukaryotes. The effect of inositol on the membrane lipid composition of C. neoformans was also examined. In contrast to the nonpathogenic yeast Saccharomyces cerevisiae, neither the PI composition nor the synthesis of methylated phospholipids was altered by exogenous inositol. Hence, C. neoformans appears to have a metabolic mechanism for maintaining a steady lipid composition regardless of the inositol in its environment.

This article has been cited by other articles:

				B. R. Steen, T. Lian, S. Zuyderduyn, W. K. MacDonald, M. Marra, S. J.M. Jones, and J. W. Kronstad Temperature-Regulated Transcription in the Pathogenic Fungus Cryptococcus neoformans Genome Res., September 1, 2002; 12(9): 1386 - 1400. [Abstract] [Full Text] [PDF]

				N. Heise, A. L.S. Gutierrez, K. A. Mattos, C. Jones, R. Wait, J. O. Previato, and L. Mendonca-Previato Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: structural differences between encapsulated and acapsular yeast forms Glycobiology, July 1, 2002; 12(7): 409 - 420. [Abstract] [Full Text] [PDF]

				M. L. Rodrigues, L. R. Travassos, K. R. Miranda, A. J. Franzen, S. Rozental, W. de Souza, C. S. Alviano, and E. Barreto-Bergter Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth Infect. Immun., December 1, 2000; 68(12): 7049 - 7060. [Abstract] [Full Text] [PDF]

				M. E. Cardenas, M. C. Cruz, M. Del Poeta, N. Chung, J. R. Perfect, and J. Heitman Antifungal Activities of Antineoplastic Agents: Saccharomyces cerevisiae as a Model System To Study Drug Action Clin. Microbiol. Rev., October 1, 1999; 12(4): 583 - 611. [Abstract] [Full Text] [PDF]

				S. M. Mandala, R. A. Thornton, J. Milligan, M. Rosenbach, M. Garcia-Calvo, H. G. Bull, G. Harris, G. K. Abruzzo, A. M. Flattery, C. J. Gill, et al. Rustmicin, a Potent Antifungal Agent, Inhibits Sphingolipid Synthesis at Inositol Phosphoceramide Synthase J. Biol. Chem., June 12, 1998; 273(24): 14942 - 14949. [Abstract] [Full Text] [PDF]

				S. M. Mandala, R. A. Thornton, M. Rosenbach, J. Milligan, M. Garcia-Calvo, H. G. Bull, and M. B. Kurtz Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis J. Biol. Chem., December 19, 1997; 272(51): 32709 - 32714. [Abstract] [Full Text] [PDF]

				R. C. Dickson, E. E. Nagiec, G. B. Wells, M. M. Nagiec, and R. L. Lester Synthesis of Mannose-(inositol-P)2-ceramide, the Major Sphingolipid in Saccharomyces cerevisiae, Requires the IPT1 (YDR072c) Gene J. Biol. Chem., November 21, 1997; 272(47): 29620 - 29625. [Abstract] [Full Text] [PDF]